Guillain-Barre syndrome during COVID-19 pandemic: an overview of the reports
AbstractSimilar to severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV), the coronavirus disease 2019 (COVID-19) has neurological symptoms. COVID-19 patients have such clinical symptoms as headache, vomiting, nausea, dizziness, myalgia, anosmia, ageusia, and disorder of consciousness. These symptoms confirm that the nervous system is involved in the COVID-19 infection. Guillain-Barr é syndrome (GBS) is a heterogeneous disorder which often follows a viral infection. According to the assessment case reports from the beginning of the COVID-19 infection so far, it is possible that GBS is linked to the COVID-19 infection. It seems that paying attention to the neurological effects o f COVID-19 is necessary.
Source: Neurological Sciences - Category: Neurology Source Type: research
More News: Brain | Coronavirus | COVID-19 | Guillain-Barr Syndrome | Headache | MERS | Middle East Health | Migraine | Neurology | Pandemics | Respiratory Medicine | SARS